Cargando…
Features of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s study
OBJECTIVES: To examine the influence of the glucocerebrosidase (GBA) mutation carrier state on age at onset of Parkinson’s disease (PD), the motor phenotype and cognitive function at baseline assessment in a large cohort of UK patients. We also analysed the prevalence of mood and behavioural problem...
Autores principales: | Malek, Naveed, Weil, Rimona S, Bresner, Catherine, Lawton, Michael A, Grosset, Katherine A, Tan, Manuela, Bajaj, Nin, Barker, Roger A, Burn, David J, Foltynie, Thomas, Hardy, John, Wood, Nicholas W, Ben-Shlomo, Yoav, Williams, Nigel W, Grosset, Donald G, Morris, Huw R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031283/ https://www.ncbi.nlm.nih.gov/pubmed/29378790 http://dx.doi.org/10.1136/jnnp-2017-317348 |
Ejemplares similares
-
Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
por: Swallow, Diane M A, et al.
Publicado: (2016) -
Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
por: Lawton, Michael, et al.
Publicado: (2018) -
Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts
por: Lawton, Michael, et al.
Publicado: (2022) -
Combining biomarkers for prognostic modelling of Parkinson’s disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022) -
Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson’s disease
por: Stoker, Thomas B, et al.
Publicado: (2020)